fda compounding semaglutide crackdown 2025 news The is proposing the removal of three GLP-1 drugs from the 503B bulks list of active ingredients that outsourcing facilities can use to make compounded medicines, the agency announced on Thursday FDA Intensifies Crackdown on GLP-1

As the levels of medication dip lower, many patients report a return of food noise. Food noise is a term used to describe constant, intrusive thoughts about food or the next meal

However, you must now account for the 'noise' of variable absorption in your statistical analysis

Ro, the direct-to-patient healthcare company, has partnered with Young Hero to launch its first-ever Super Bowl commercial starring its GLP-1 patient ambassador, Serena Williams

NAION is a very rare eye disease, and it's not an adverse drug reaction listed on the labels for semaglutide in the form of Ozempic, Rybelsus and Wegovy, Novo Nordisk said in a statement